FEMALE | |
---|---|
Right | |
C50.211 | Malignant neoplasm of upper-inner quadrant, right female breast |
C50.311 | Malignant neoplasm of lower-inner quadrant, right female breast |
C50.411 | Malignant neoplasm of upper-outer quadrant, right female breast |
2018/2019 ICD-10-CM Diagnosis Code C50.211. Malignant neoplasm of upper-inner quadrant of right female breast. C50.211 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Breast Cancer ICD-10 Code Reference Sheet. FEMALE. Right. C50.011. Malignant neoplasm of nipple and areola, right female breast. C50.111. Malignant neoplasm of central portion, right female breast. C50.211. Malignant neoplasm of upper-inner quadrant, right female breast.
C50.211 is a billable ICD code used to specify a diagnosis of malignant neoplasm of upper-inner quadrant of right female breast. A 'billable code' is detailed enough to be used to specify a medical diagnosis.
Malignant neoplasm of unspecified site of right female breast 1 C50.911 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 Short description: Malignant neoplasm of unsp site of right female breast 3 The 2020 edition of ICD-10-CM C50.911 became effective on October 1, 2019. More items...
ICD-10 code C50. 411 for Malignant neoplasm of upper-outer quadrant of right female breast is a medical classification as listed by WHO under the range - Malignant neoplasms .
Malignant neoplasm of unspecified site of unspecified female breast. C50. 919 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM C50.
ICD-10 code Z85. 3 for Personal history of malignant neoplasm of breast is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
39 (Encounter for other screening for malignant neoplasm of breast). Z12. 39 is the correct code to use when employing any other breast cancer screening technique (besides mammogram) and is generally used with breast MRIs.
C50. 911 - Malignant neoplasm of unspecified site of right female breast | ICD-10-CM.
ICD-10 code Z51. 11 for Encounter for antineoplastic chemotherapy is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Patients with history of malignant neoplasm, and not currently under treatment for cancer, and there is no evidence of existing primary malignancy, a code from category Z85, personal history of malignant neoplasm, should be used. Breast Cancer Scenario: Should be coded as historical (Z85.
ICD-10 Code for Family history of malignant neoplasm of breast- Z80. 3- Codify by AAPC.
11.
Z12. 31 (Encounter for screening mammogram for malignant neoplasm of breast) is reported for screening mammograms while Z12. 39 (Encounter for other screening for malignant neoplasm of breast) has been established for reporting screening studies for breast cancer outside the scope of mammograms.
A screening colonoscopy should be reported with the following International Classification of Diseases, 10th edition (ICD-10) codes: Z12. 11: Encounter for screening for malignant neoplasm of the colon. Z80. 0: Family history of malignant neoplasm of digestive organs.
Z12. 31, Encounter for screening mammogram for malignant neoplasm of breast, is the primary diagnosis code assigned for a screening mammogram. If the mammogram is diagnostic, the ICD-10-CM code assigned is the reason the diagnostic mammogram was performed.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm. Morphology [Histology] Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, ...